Market Overview:
The global punicalagin market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing demand for natural products, rising awareness about the health benefits of punicalagin, and growing research on the therapeutic potential of punicalagin. However, factors such as high cost and limited availability are restraining the growth of this market. On the basis of type, more than 98% segment is expected to dominate the global punicalagin market during 2018-2030. This segment is projected to grow at a CAGR of XX%. On account of its high purity and therapeutic potential, this segment is witnessing increasing demand from medical and research applications.
Product Definition:
Punicalagin is a natural compound found in pomegranate. It has potent antioxidant and anti-inflammatory properties.
More than 98%:
More than 98% is a term used for the concentration of unbound fractional polysaccharides that exceed the limit of98% in comparison to its counterpart. More than 98% has been proved to be more effective in comparison with other fractions as it includes higher molecular weight which results into enhanced biological activity.
The most important factor contributing towards this increase in biological activity is associated with increased hydrophobicity.
Less Than 98%:
less than 98% is a range between 97.5% to 99.4%. It means that the amount of impurities present in the final product may not be less than 98%, but it can also be equal to or more than that limit as well depending upon the quality and purity required by consumers.
The main function of less than 98% purification is to remove contaminants, like metals, from the end product using distillation or other processes like filtration.
Application Insights:
Medical application dominated the global market in 2017. The product is used for various medical conditions such as cardiovascular diseases, diabetes, osteoarthritis and rheumatoid arthritis. It is also used for skin disorders such as acne and eczema. However, the use of products with synthetic derivatives should be preferred over the natural type since they are proven to be safer and effective than the latter.
The research segment was valued at USD 55 million in 2017 owing to rising applications of punicalagin in academic research on animals particularly swine species that develop lesions after being injected with a vaccine made from porcine proteins known to trigger an autoimmune response in humans (IgG). This has led researchers around the world to investigate new therapeutic areas where this marine-derived compound can help treat human diseases by triggering anti-inflammatory responses without causing any harm or side effects towards patients.
Regional Analysis:
North America dominated the global Punicalagin market in 2017. The region is expected to maintain its position during the forecast period. Increasing prevalence of skin diseases, rising consumer awareness regarding available treatment options, and high adoption of cosmetic products containing natural ingredients are some major factors contributing to the growth of this regional market.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to increasing demand from countries such as China and India due to growing population and rising disposable income among consumers. Moreover, increasing medical tourism in these countries can also be attributed for rapid increase in demand for medicines that contain punicalagins such as corticosteroids used for treating various skin diseases including eczema and psoriasis which are major applications driving this regional market forward.
Growth Factors:
- Increasing demand for natural and organic products
- Rising awareness about the health benefits of punicalagin
- Growing popularity of pomegranate juice and other products containing punicalagin
- Rising demand from emerging markets such as China and India
- Technological advancements that facilitate the extraction and purification of punicalagin
Scope Of The Report
Report Attributes
Report Details
Report Title
Punicalagin Market Research Report
By Type
More than 98%, Less Than 98%
By Application
Medical, Research
By Companies
BOC Sciences, Merck, ApexBio Technology, Cayman Chemical, Merck, Chengdu Must Bio-Technology, BioCrick BioTech, AdooQ BioScience, Fengchen Group, ChemScence
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Punicalagin Market Report Segments:
The global Punicalagin market is segmented on the basis of:
Types
More than 98%, Less Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- Merck
- ApexBio Technology
- Cayman Chemical
- Merck
- Chengdu Must Bio-Technology
- BioCrick BioTech
- AdooQ BioScience
- Fengchen Group
- ChemScence
Highlights of The Punicalagin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- More than 98%
- Less Than 98%
- By Application:
- Medical
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Punicalagin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Punicalagin is a polyphenol found in grapefruit juice. It has antioxidant properties and may help reduce the risk of certain cancers.
Some of the key players operating in the punicalagin market are BOC Sciences, Merck, ApexBio Technology, Cayman Chemical, Merck, Chengdu Must Bio-Technology, BioCrick BioTech, AdooQ BioScience, Fengchen Group, ChemScence.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Punicalagin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Punicalagin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Punicalagin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Punicalagin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Punicalagin Market Size & Forecast, 2020-2028
4.5.1 Punicalagin Market Size and Y-o-Y Growth
4.5.2 Punicalagin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 More than 98%
5.2.2 Less Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Punicalagin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Punicalagin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 More than 98%
9.6.2 Less Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 More than 98%
10.6.2 Less Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 More than 98%
11.6.2 Less Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 More than 98%
12.6.2 Less Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 More than 98%
13.6.2 Less Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Punicalagin Market: Competitive Dashboard
14.2 Global Punicalagin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 Merck
14.3.3 ApexBio Technology
14.3.4 Cayman Chemical
14.3.5 Merck
14.3.6 Chengdu Must Bio-Technology
14.3.7 BioCrick BioTech
14.3.8 AdooQ BioScience
14.3.9 Fengchen Group
14.3.10 ChemScence
